Beximco Pharmaceuticals (BXP) Competitors GBX 45 +1.50 (+3.45%) As of 08/6/2025 07:52 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock BXP vs. LSE, WPY, AHT, LAND, TW, SIR, SAFE, CLIN, EVR, and BGSCShould you be buying Beximco Pharmaceuticals stock or one of its competitors? The main competitors of Beximco Pharmaceuticals include London Stock Exchange Group plc (LSE.L) (LSE), Worldpay (WPY), Ashtead Group (AHT), Land Securities Group (LAND), Taylor Wimpey (TW), Secure Income REIT (SIR), Safestore (SAFE), Clinigen Group (CLIN), EVRAZ (EVR), and BMO Global Smaller Companies (BGSC). These companies are all part of the "trading" industry. Beximco Pharmaceuticals vs. Its Competitors London Stock Exchange Group plc (LSE.L) Worldpay Ashtead Group Land Securities Group Taylor Wimpey Secure Income REIT Safestore Clinigen Group EVRAZ BMO Global Smaller Companies Beximco Pharmaceuticals (LON:BXP) and London Stock Exchange Group plc (LSE.L) (LON:LSE) are both large-cap trading companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, dividends, earnings and risk. Is BXP or LSE more profitable? Beximco Pharmaceuticals has a net margin of 13.71% compared to London Stock Exchange Group plc (LSE.L)'s net margin of 0.00%. Beximco Pharmaceuticals' return on equity of 13.12% beat London Stock Exchange Group plc (LSE.L)'s return on equity.Company Net Margins Return on Equity Return on Assets Beximco Pharmaceuticals13.71% 13.12% 6.97% London Stock Exchange Group plc (LSE.L) N/A N/A N/A Do insiders and institutionals hold more shares of BXP or LSE? 1.7% of Beximco Pharmaceuticals shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has preferable earnings and valuation, BXP or LSE? Beximco Pharmaceuticals has higher revenue and earnings than London Stock Exchange Group plc (LSE.L). London Stock Exchange Group plc (LSE.L) is trading at a lower price-to-earnings ratio than Beximco Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeximco Pharmaceuticals£7.08T0.00£970.84B£9.324.83London Stock Exchange Group plc (LSE.L)£2.41B0.00N/A£112.40N/A Does the media refer more to BXP or LSE? In the previous week, Beximco Pharmaceuticals had 1 more articles in the media than London Stock Exchange Group plc (LSE.L). MarketBeat recorded 1 mentions for Beximco Pharmaceuticals and 0 mentions for London Stock Exchange Group plc (LSE.L). Beximco Pharmaceuticals' average media sentiment score of 0.10 beat London Stock Exchange Group plc (LSE.L)'s score of 0.00 indicating that Beximco Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Beximco Pharmaceuticals Neutral London Stock Exchange Group plc (LSE.L) Neutral Is BXP or LSE a better dividend stock? Beximco Pharmaceuticals pays an annual dividend of GBX 3 per share and has a dividend yield of 6.7%. London Stock Exchange Group plc (LSE.L) pays an annual dividend of GBX 73 per share. Beximco Pharmaceuticals pays out 32.2% of its earnings in the form of a dividend. London Stock Exchange Group plc (LSE.L) pays out 64.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Beximco Pharmaceuticals is clearly the better dividend stock, given its higher yield and lower payout ratio. SummaryBeximco Pharmaceuticals beats London Stock Exchange Group plc (LSE.L) on 9 of the 11 factors compared between the two stocks. Get Beximco Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BXP vs. The Competition Export to ExcelMetricBeximco PharmaceuticalsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£30.68B£2.15B£5.57B£3.07BDividend Yield8.67%2.92%4.31%5.02%P/E Ratio4.834.2129.37167.82Price / Sales0.00603.86444.18340,578.78Price / CashN/A10.3535.8427.97Price / Book0.0010.848.084.55Net Income£970.84B£21.15B£3.26B£5.90B7 Day Performance15.38%0.61%0.45%0.54%1 Month Performance21.62%3.97%4.83%4.30%1 Year Performance24.57%4.15%30.28%58.40% Beximco Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BXPBeximco PharmaceuticalsN/AGBX 45+3.4%N/A+21.6%£30.68B£7.08T4.835,500News CoverageLSELondon Stock Exchange Group plc (LSE.L)N/AN/AN/AN/A£30.31B£2.41B76.694,965WPYWorldpayN/AN/AN/AN/A£29.39B£4.04B194.44190AHTAshtead Group3.1225 of 5 starsGBX 5,070-0.2%GBX 6,345+25.1%-1.5%£27.68B£13.67B18.04120Dividend CutLANDLand Securities Group2.517 of 5 starsGBX 577.50-0.9%GBX 671+16.2%-5.3%£4.28B£823.49M-13.39598TWTaylor Wimpey4.1725 of 5 starsGBX 107.15-1.6%GBX 151.40+41.3%-32.8%£3.85B£3.45B15.631,090News CoverageEarnings ReportAnalyst ForecastHigh Trading VolumeSIRSecure Income REITN/AN/AN/AN/A£1.49B£122.40M743.55N/ASAFESafestore3.2485 of 5 starsGBX 682+0.7%N/A-16.1%£1.49B£222.85M5.62120CLINClinigen GroupN/AN/AN/AN/A£1.23B£565.60M64.691,000EVREVRAZ0.6987 of 5 starsGBX 81flatN/AN/A£1.18B£15.40B42.1971,591BGSCBMO Global Smaller CompaniesN/AN/AN/AN/A£769.56M£303.85M2.77N/A Related Companies and Tools Related Companies London Stock Exchange Group plc (LSE.L) Competitors Worldpay Competitors Ashtead Group Competitors Land Securities Group Competitors Taylor Wimpey Competitors Secure Income REIT Competitors Safestore Competitors Clinigen Group Competitors EVRAZ Competitors BMO Global Smaller Companies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BXP) was last updated on 8/7/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BXP Stock Alerts